These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19588124)

  • 1. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.
    Sink KS; Segovia KN; Nunes EJ; Collins LE; Vemuri VK; Thakur G; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2009 Oct; 206(2):223-32. PubMed ID: 19588124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.
    Sink KS; McLaughlin PJ; Wood JA; Brown C; Fan P; Vemuri VK; Peng Y; Olszewska T; Thakur GA; Makriyannis A; Parker LA; Salamone JD
    Neuropsychopharmacology; 2008 Mar; 33(4):946-55. PubMed ID: 17581535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113.
    Sink KS; Vemuri VK; Wood J; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2009 Jan; 91(3):303-6. PubMed ID: 18703081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats.
    Sink KS; Segovia KN; Collins LE; Markus EJ; Vemuri VK; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2010 Jun; 95(4):479-84. PubMed ID: 20347865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior.
    Sink KS; Vemuri VK; Olszewska T; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2008 Mar; 196(4):565-74. PubMed ID: 18004546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
    Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
    Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions.
    Salamone JD; McLaughlin PJ; Sink K; Makriyannis A; Parker LA
    Physiol Behav; 2007 Jul; 91(4):383-8. PubMed ID: 17521686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.
    Sink KS; Segovia KN; Sink J; Randall PA; Collins LE; Correa M; Markus EJ; Vemuri VK; Makriyannis A; Salamone JD
    Eur Neuropsychopharmacol; 2010 Feb; 20(2):112-22. PubMed ID: 20015619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
    Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
    Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neutral CB1 receptor antagonist reduces weight gain in rat.
    Chambers AP; Vemuri VK; Peng Y; Wood JT; Olszewska T; Pittman QJ; Makriyannis A; Sharkey KA
    Am J Physiol Regul Integr Comp Physiol; 2007 Dec; 293(6):R2185-93. PubMed ID: 17959701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.
    Adamczyk P; Miszkiel J; McCreary AC; Filip M; Papp M; Przegaliński E
    Brain Res; 2012 Mar; 1444():45-54. PubMed ID: 22325096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior.
    Randall PA; Vemuri VK; Segovia KN; Torres EF; Hosmer S; Nunes EJ; Santerre JL; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2010 Nov; 97(1):179-84. PubMed ID: 20713079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats.
    Limebeer CL; Vemuri VK; Bedard H; Lang ST; Ossenkopp KP; Makriyannis A; Parker LA
    Br J Pharmacol; 2010 Sep; 161(2):336-49. PubMed ID: 20735419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid CB
    He XH; Jordan CJ; Vemuri K; Bi GH; Zhan J; Gardner EL; Makriyannis A; Wang YL; Xi ZX
    Acta Pharmacol Sin; 2019 Mar; 40(3):365-373. PubMed ID: 29967454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties.
    Bergman J; Delatte MS; Paronis CA; Vemuri K; Thakur GA; Makriyannis A
    Physiol Behav; 2008 Mar; 93(4-5):666-70. PubMed ID: 18076956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference.
    Rezayof A; Sardari M; Zarrindast MR; Nayer-Nouri T
    Behav Brain Res; 2011 Jun; 220(1):1-8. PubMed ID: 21262265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.
    Cippitelli A; Bilbao A; Hansson AC; del Arco I; Sommer W; Heilig M; Massi M; Bermúdez-Silva FJ; Navarro M; Ciccocioppo R; de Fonseca FR;
    Eur J Neurosci; 2005 Apr; 21(8):2243-51. PubMed ID: 15869521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.